94 related articles for article (PubMed ID: 20430165)
1. Effect of pretransplantation hemoglobin blood concentration on renal allograft survival and function.
Abou-Jaoude MM; Nawfal N; Najm R; Honeidi M; Shaheen J; Almawi WY
Transplant Proc; 2010 Apr; 42(3):760-2. PubMed ID: 20430165
[TBL] [Abstract][Full Text] [Related]
2. Effect of pre-transplantation hemoglobin concentration on prognosis of renal transplant recipients.
Na N; Hong LQ; Miao B; Hua XF; Huang ZY
Chin Med J (Engl); 2011 Apr; 124(8):1213-6. PubMed ID: 21542999
[TBL] [Abstract][Full Text] [Related]
3. Effect of pretransplant hemoglobin blood level on kidney transplant outcome.
Abou-Jaoude MM; Nawfal N; Najm R; Shaheen J; Almawi WY
Exp Clin Transplant; 2009 Dec; 7(4):214-7. PubMed ID: 20353369
[TBL] [Abstract][Full Text] [Related]
4. Anemia in living donor kidney transplantation.
Sert I; Colak H; Tugmen C; Dogan SM; Karaca C
Transplant Proc; 2013; 45(6):2238-43. PubMed ID: 23714109
[TBL] [Abstract][Full Text] [Related]
5. Effect of pretransplantation body mass index on allograft function and patient survival after renal transplantation.
Abou-Jaoude MM; Nawfal N; Najm R; Honeidi M; Shaheen J; Almawi WY
Transplant Proc; 2010 Apr; 42(3):785-8. PubMed ID: 20430171
[TBL] [Abstract][Full Text] [Related]
6. Could prophylactic monoclonal antibody improve kidney graft survival?
Pourmand G; Saraji A; Salem S; Mehrsai A; Nikoobakht MR; Taherimahmoudi M; Rezaeidanesh M; Asadpour A
Transplant Proc; 2009 Sep; 41(7):2794-6. PubMed ID: 19765437
[TBL] [Abstract][Full Text] [Related]
7. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM
Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476
[TBL] [Abstract][Full Text] [Related]
8. Can preemptive kidney transplantation guarantee longer graft survival in living-donor kidney transplantation? Single-center study.
Jung GO; Moon JI; Kim JM; Choi GS; Kwon CH; Cho JW; Kim SJ
Transplant Proc; 2010 Apr; 42(3):766-74. PubMed ID: 20430167
[TBL] [Abstract][Full Text] [Related]
9. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
[TBL] [Abstract][Full Text] [Related]
10. Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation.
Tan HP; Kaczorowski D; Basu A; McCauley J; Marcos A; Donaldson J; Unruh M; Randhawa P; Zeevi A; Shapiro R
Transplant Proc; 2005 Dec; 37(10):4235-40. PubMed ID: 16387087
[TBL] [Abstract][Full Text] [Related]
11. Daclizumab versus anti-thymocyte globulin-fresenius as induction therapy for low-risk kidney transplant recipients.
Abou-Jaoude MM; Ghantous I; Najm R; Afif C; Almawi WY
Transplant Proc; 2003 Nov; 35(7):2731-2. PubMed ID: 14612096
[No Abstract] [Full Text] [Related]
12. Clinical experience with thymoglobulin and antithymocyte globulin-Fresenius as induction therapy in renal transplant patients: a retrospective study.
Cicora F; Mos F; Paz M; Roberti J
Exp Clin Transplant; 2013 Oct; 11(5):418-22. PubMed ID: 23909577
[TBL] [Abstract][Full Text] [Related]
13. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
14. The outcome of induction therapy with monoclonal antibodies in kidney transplantation among Iranian patients: a prospective study.
Naderi GH; Mehraban D; Ganji MR; Jafarpouriani M; Latif AH
Transplant Proc; 2009 Sep; 41(7):2768-71. PubMed ID: 19765430
[TBL] [Abstract][Full Text] [Related]
15. A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin.
Wang W; Yin H; Li XB; Hu XP; Yang XY; Liu H; Ren L; Wang Y; Zhang XD
Chin Med J (Engl); 2012 Mar; 125(6):1135-40. PubMed ID: 22613543
[TBL] [Abstract][Full Text] [Related]
16. Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study.
Kim JM; Jang HR; Kwon CH; Huh WS; Kim GS; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2012 Jan; 44(1):167-70. PubMed ID: 22310606
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment of low dose Anti-Thymocyte Globulin (ATG), Rituximab and high dose Sirolimus as induction agents in immune-conditioned recipients.
Ravichandran P; Natrajan T; Jaganathan R
Int Immunopharmacol; 2006 Dec; 6(13-14):1973-6. PubMed ID: 17161350
[TBL] [Abstract][Full Text] [Related]
18. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
Foster CE; Weng RR; Piper M; Laugenou K; Ichii H; Lakey J; Malinoski D
Transplant Proc; 2012 Jan; 44(1):164-6. PubMed ID: 22310605
[TBL] [Abstract][Full Text] [Related]
19. Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin.
Reddy KS; Devarapalli Y; Mazur M; Hamawi K; Chakkera H; Moss A; Mekeel K; Post D; Heilman R; Mulligan D
Transplant Proc; 2010; 42(6):2006-8. PubMed ID: 20692393
[TBL] [Abstract][Full Text] [Related]
20. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
